K74.3 Primary biliary cirrhosis

Name of the Condition

• Primary Biliary Cirrhosis (ICD-10-CM Code: K74.3)

Summary

Primary biliary cirrhosis is a chronic liver disease characterized by progressive destruction of the bile ducts within the liver. This leads to impaired bile flow, inflammation, and eventual scarring (cirrhosis) of liver tissue. The condition primarily affects women and typically progresses slowly over years. It is an autoimmune disorder, though the exact triggers remain unclear.

Causes

The condition is caused by an autoimmune response that targets and damages the small bile ducts in the liver. This immune-mediated destruction impairs bile drainage, leading to bile accumulation, inflammation, and fibrosis. While the underlying cause of the autoimmune attack is not fully understood, genetic and environmental factors are believed to contribute.

Risk Factors

• Female gender (most commonly diagnosed in women aged 30–60)
• Family history of autoimmune diseases
• Presence of certain genetic markers (e.g., HLA types)
• Coexisting autoimmune conditions (e.g., Sjögren’s syndrome, thyroid disease)

Symptoms

• Persistent fatigue and weakness
• Itchy skin (pruritus)
• Dry eyes and mouth
• Jaundice (yellowing of skin or eyes)
• Swelling in the legs or abdomen (edema/ascites)
• Unexplained weight loss
• Elevated cholesterol levels
• Bone pain or fractures (due to vitamin D malabsorption)

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests typically show elevated alkaline phosphatase and antimitochondrial antibodies (AMA), which are highly specific for the condition. Imaging studies (e.g., ultrasound, MRI) assess liver structure and bile ducts, while a liver biopsy may confirm bile duct damage and scarring.

Treatment Options

Treatment focuses on managing symptoms, slowing disease progression, and preventing complications. Ursodeoxycholic acid (UDCA) is a first-line therapy to improve bile flow and reduce liver damage. Symptomatic treatments include antihistamines or cholestyramine for itching, and vitamin supplements (A, D, K) to address deficiencies. In advanced cases, liver transplantation may be necessary.

Prognosis and Follow-Up

Prognosis varies, with some patients remaining stable for years while others progress to cirrhosis. Regular monitoring of liver function, imaging, and symptom management is essential. Follow-up care includes routine blood tests, bone density scans, and vaccinations (e.g., for hepatitis A/B) to prevent additional liver stress.

Complications

• Progressive cirrhosis and liver failure
• Portal hypertension (increased blood pressure in liver veins)
• Esophageal varices (enlarged veins in the esophagus)
• Osteoporosis (due to vitamin D malabsorption)
• Increased risk of liver cancer (hepatocellular carcinoma)

Lifestyle & Prevention

• Avoid alcohol and unnecessary medications (consult a provider before use)
• Maintain a balanced diet with adequate calories and nutrients
• Stay hydrated and manage pruritus with prescribed therapies
• Engage in regular, moderate exercise to support overall health
• Avoid exposure to toxins or chemicals that may stress the liver

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Severe abdominal pain or swelling
• Sudden jaundice or dark urine
• Uncontrolled itching or bleeding
• Signs of infection (e.g., fever, chills)
• Confusion or changes in mental status (hepatic encephalopathy)

Tips for Medical Coders

Document the presence of antimitochondrial antibodies (AMA) or other autoimmune markers when available, as these support the diagnosis. Note any associated conditions (e.g., osteoporosis, vitamin deficiencies) to ensure comprehensive coding. Avoid coding for "biliary cirrhosis" without specifying "primary" unless the documentation confirms the underlying cause. Ensure the code K74.3 is used only when the condition is documented as primary biliary cirrhosis, distinguishing it from other biliary or cirrhotic disorders.